ストックスクリーナーアプリを入手
101.09
0.40%
0.40
前日終値:
$100.69
開ける：
$100.6
24時間の取引高:
44.61M
Relative Volume:
3.17
時価総額：
$250.91B
収益：
$63.90B
当期純損益:
$19.05B
株価収益率:
13.37
EPS:
7.5596
ネットキャッシュフロー:
$13.05B
1週間 パフォーマンス:
+0.79%
1か月 パフォーマンス:
+6.35%
6か月 パフォーマンス:
+27.49%
1年 パフォーマンス:
+1.58%
1日の値動き範囲:
$100.11
$102.19
1週間の範囲:
$96.79
$102.19
52週間の値動き範囲:
$73.31
$105.84
Merck Co Inc Stock (MRK) Company Profile
MRK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
101.09 | 249.91B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,071.44 | 945.93B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
206.37 | 501.88B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
226.82 | 393.81B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
136.06 | 259.56B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-18 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-10-13 | 再開されました | Citigroup | Neutral |
| 2025-09-17 | ダウングレード | Berenberg | Buy → Hold |
| 2025-05-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Neutral |
| 2025-02-18 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-02-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-01-08 | ダウングレード | Truist | Buy → Hold |
| 2024-12-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 再開されました | BofA Securities | Buy |
| 2024-12-04 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-11 | ダウングレード | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-03-11 | ダウングレード | Societe Generale | Hold → Sell |
| 2024-01-04 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Buy |
| 2023-10-27 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | アップグレード | UBS | Neutral → Buy |
| 2023-07-14 | 開始されました | HSBC Securities | Hold |
| 2023-04-13 | アップグレード | Citigroup | Neutral → Buy |
| 2023-03-28 | ダウングレード | Societe Generale | Buy → Hold |
| 2023-03-13 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 開始されました | Jefferies | Buy |
| 2023-02-22 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-10-10 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-09-14 | アップグレード | Berenberg | Hold → Buy |
| 2022-07-06 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 再開されました | SVB Leerink | Outperform |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 開始されました | Goldman | Buy |
| 2021-12-16 | 開始されました | Daiwa Securities | Neutral |
| 2021-12-13 | ダウングレード | UBS | Buy → Neutral |
| 2021-12-09 | 開始されました | Wells Fargo | Overweight |
| 2021-12-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-11-29 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-11-01 | アップグレード | Argus | Hold → Buy |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-05-20 | ダウングレード | Argus | Buy → Hold |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 再開されました | Bernstein | Outperform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-08-03 | アップグレード | Goldman | Neutral → Buy |
| 2020-06-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-16 | 開始されました | SVB Leerink | Outperform |
| 2019-07-03 | 開始されました | Mizuho | Buy |
| 2019-05-28 | 開始されました | Goldman | Neutral |
| 2019-05-13 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 繰り返されました | Citigroup | Buy |
| 2018-10-09 | 再開されました | Guggenheim | Buy |
| 2018-04-23 | アップグレード | Goldman | Neutral → Buy |
| 2018-04-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-03-12 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 繰り返されました | Leerink Partners | Mkt Perform |
| 2018-02-07 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2018-01-16 | アップグレード | SunTrust | Hold → Buy |
すべてを表示
Merck Co Inc (MRK) 最新ニュース
Rahway-Based Merck & Co., Inc. Recognized at 46th Annual Edison Patent Awards - TAPinto
Merck & Co., Inc. $MRK Shares Sold by Perpetual Ltd - MarketBeat
Secure Asset Management LLC Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - Benzinga
Merck (MRK) Stock After Hours on Dec. 19, 2025: Trump Drug-Pricing Deal, FDA Fast-Track Vouchers, and What to Watch Before Markets Reopen - ts2.tech
Top Research Reports for NVIDIA, Netflix & Merck - TradingView — Track All Markets
US FDA grants priority vouchers to Merck's cholesterol pill, cancer therapy - Reuters
Merck (MRK) Stock News and Forecasts for Dec. 19, 2025: Drug-Pricing Deals, FDA Fast-Track Catalysts, and Wall Street Targets - ts2.tech
Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans - Business Wire
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Benzinga
Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning Center - CSRwire
Merck (MRK)’s CEO Has a “Better Hand,” Says Jim Cramer - Insider Monkey
Trump to announce new deals to lower drug prices, White House says - Reuters
Merck & Co., Inc. $MRK Stock Holdings Boosted by Talbot Financial LLC - MarketBeat
Merck & Co., Inc. : Technically solid - marketscreener.com
Merck's Deep Pipeline And Cash Flow Strength Support The Bull Case - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.6% Following Analyst Upgrade - MarketBeat
Merck & Company, Inc. (MRK) Stock News and Forecasts: FDA Fast-Track Signals, BMO Upgrade, and a New Keytruda–Padcev Win (Dec. 18, 2025) - ts2.tech
Merck Cholesterol, Cancer Drugs May Enter FDA Fast-Track Program: Report - Benzinga
Merck & Co., Inc. (NYSE:MRK) Upgraded at BMO Capital Markets - MarketBeat
FDA Mulls National Priority Vouchers for Two Potential Merck Blockbusters: Report - BioSpace
Here Are Thursday’s Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More - 24/7 Wall St.
27,329 Shares in Merck & Co., Inc. $MRK Purchased by Montecito Bank & Trust - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
BMO Capital Upgrades Merck & Co. to Outperform From Market Perform, Adjusts PT to $130 From $82 - marketscreener.com
Czech National Bank Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co Inc (NYSE:MRK) S&P 500 Futures Healthcare Scale Research - Kalkine Media
Merck & Co., Inc. (NYSE:MRK) Shares Acquired Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
Merck (MRK) Stock After Hours: FDA Fast‑Track Vouchers, Keytruda‑Padcev Trial Win, and What to Watch Before the Dec. 18 Market Open - ts2.tech
Merck & Co., Inc. (MRK) sees mixed analyst views as Europe advances WINREVAIR review - MSN
Merck & Co., Inc. (MRK) Sees Mixed Analyst Views as Europe Advances WINREVAIR Review - Insider Monkey
Merck cholesterol, cancer therapies to receive national priority vouchersreport - Seeking Alpha
Exclusive-US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers - Yahoo Finance
Why Merck Co Inc Common Stock 6MK0 stock stays undervaluedQuarterly Risk Review & Risk Controlled Stock Alerts - moha.gov.vn
BofA Turns More Positive on Merck (MRK) Pipeline - Finviz
BTK Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Merck's Keytruda-Padcev Combo Boosts Survival In Pivotal Bladder Cancer Trial - Benzinga
Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back - Benzinga
Union Bancaire Privee UBP SA Has $34.88 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck Animal Health Announces Availability of Circumvent® CL, a Ready-to-use Vaccine Protecting Pigs Against Porcine Circovirus Types 2a and 2d and Lawsonia intracellularis - American Ag Network
Quintet Private Bank Europe S.A. Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Insight Wealth Strategies LLC Purchases New Position in Merck & Co., Inc. $MRK - MarketBeat
Assenagon Asset Management S.A. Buys 3,618,532 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Down 2%Here's Why - MarketBeat
Merck (MRK) Price Target Lifted at Morgan Stanley as Biopharma Outlook Improves - Insider Monkey
Merck (MRK) Stock News Today: Why Shares Slid on Dec. 16, 2025 as Analysts Reassess Keytruda, Winrevair, and Merck’s Post‑Patent Strategy - ts2.tech
Trust Co of the South Sells 14,016 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Holdings Lowered by Westwood Holdings Group Inc. - MarketBeat
Red Spruce Capital LLC Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Nilsine Partners LLC - MarketBeat
Iowa State Bank Cuts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc (MRK) 財務データ
収益
当期純利益
現金流量
EPS
0.58%
大文字化:
|
ボリューム (24 時間):